Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

38 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The Rheumatology Drugs for COVID-19 Management: Which and When?
Atzeni F, Masala IF, Rodríguez-Carrio J, Ríos-Garcés R, Gerratana E, La Corte L, Giallanza M, Nucera V, Riva A, Espinosa G, Cervera R. Atzeni F, et al. Among authors: masala if. J Clin Med. 2021 Feb 16;10(4):783. doi: 10.3390/jcm10040783. J Clin Med. 2021. PMID: 33669218 Free PMC article. Review.
The effect of drugs used in rheumatology for treating SARS-CoV2 infection.
Atzeni F, Gerratana E, Giallanza M, La Corte L, Nucera V, Miceli G, Sangari D, Masala IF. Atzeni F, et al. Among authors: masala if. Expert Opin Biol Ther. 2021 Feb;21(2):219-228. doi: 10.1080/14712598.2020.1817372. Epub 2020 Sep 18. Expert Opin Biol Ther. 2021. PMID: 32866053 Review.
One year in review 2019: fibromyalgia.
Atzeni F, Talotta R, Masala IF, Giacomelli C, Conversano C, Nucera V, Lucchino B, Iannuccelli C, Di Franco M, Bazzichi L. Atzeni F, et al. Among authors: masala if. Clin Exp Rheumatol. 2019 Jan-Feb;37 Suppl 116(1):3-10. Epub 2019 Feb 6. Clin Exp Rheumatol. 2019. PMID: 30747097 Free article. Review.
Concerns about the safety of anti-TNF agents when treating rheumatic diseases.
Atzeni F, Nucera V, Gerratana E, Cirillo M, Marino F, Miceli G, Sangari D, Boccassini L, Masala IF. Atzeni F, et al. Among authors: masala if. Expert Opin Drug Saf. 2020 Jun;19(6):695-705. doi: 10.1080/14740338.2020.1763299. Epub 2020 May 13. Expert Opin Drug Saf. 2020. PMID: 32401624 Review.
Toxicological considerations in the treatment of axial spondylo-arthritis.
Marino F, D'Angelo S, Masala IF, Gerratana E, Nucera V, La Corte L, Giallanza M, Sarzi-Puttini P, Atzeni F. Marino F, et al. Among authors: masala if. Expert Opin Drug Metab Toxicol. 2020 Aug;16(8):663-672. doi: 10.1080/17425255.2020.1783240. Epub 2020 Jun 27. Expert Opin Drug Metab Toxicol. 2020. PMID: 32552128 Review.
One year in review 2021: fibromyalgia.
Alciati A, Nucera V, Masala IF, Giallanza M, La Corte L, Giorgi V, Sarzi-Puttini P, Atzeni F. Alciati A, et al. Among authors: masala if. Clin Exp Rheumatol. 2021 May-Jun;39 Suppl 130(3):3-12. doi: 10.55563/clinexprheumatol/gz4i3i. Epub 2021 May 13. Clin Exp Rheumatol. 2021. PMID: 34001307 Free article. Review.
From autoinflammation to autoimmunity: old and recent findings.
Caso F, Costa L, Nucera V, Barilaro G, Masala IF, Talotta R, Caso P, Scarpa R, Sarzi-Puttini P, Atzeni F. Caso F, et al. Among authors: masala if. Clin Rheumatol. 2018 Sep;37(9):2305-2321. doi: 10.1007/s10067-018-4209-9. Epub 2018 Jul 16. Clin Rheumatol. 2018. PMID: 30014358 Review.
38 results